AU5864796A - Multiply-substituted fullerenes and methods for their prepar ation and characterization - Google Patents

Multiply-substituted fullerenes and methods for their prepar ation and characterization

Info

Publication number
AU5864796A
AU5864796A AU58647/96A AU5864796A AU5864796A AU 5864796 A AU5864796 A AU 5864796A AU 58647/96 A AU58647/96 A AU 58647/96A AU 5864796 A AU5864796 A AU 5864796A AU 5864796 A AU5864796 A AU 5864796A
Authority
AU
Australia
Prior art keywords
multiply
characterization
methods
substituted fullerenes
prepar ation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58647/96A
Inventor
Quing Lu
Randall B Murphy
Stephen R. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sphere Biosystems Inc
Original Assignee
Sphere Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sphere Biosystems Inc filed Critical Sphere Biosystems Inc
Publication of AU5864796A publication Critical patent/AU5864796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11CSTATIC STORES
    • G11C13/00Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
    • G11C13/02Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using elements whose operation depends upon chemical change
    • G11C13/025Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using elements whose operation depends upon chemical change using fullerenes, e.g. C60, or nanotubes, e.g. carbon or silicon nanotubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • C07C45/85Separation; Purification; Stabilisation; Use of additives by treatment giving rise to a chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11CSTATIC STORES
    • G11C13/00Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
    • G11C13/0002Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using resistive RAM [RRAM] elements
    • G11C13/0009RRAM elements whose operation depends upon chemical change
    • G11C13/0014RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11CSTATIC STORES
    • G11C13/00Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
    • G11C13/0002Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using resistive RAM [RRAM] elements
    • G11C13/0009RRAM elements whose operation depends upon chemical change
    • G11C13/0014RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material
    • G11C13/0019RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material comprising bio-molecules
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2604/00Fullerenes, e.g. C60 buckminsterfullerene or C70
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
AU58647/96A 1995-05-19 1996-05-17 Multiply-substituted fullerenes and methods for their prepar ation and characterization Abandoned AU5864796A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US44485495A 1995-05-19 1995-05-19
US444854 1995-05-19
US50920995A 1995-07-31 1995-07-31
US509209 1995-07-31
PCT/US1996/007216 WO1996036631A1 (en) 1995-05-19 1996-05-17 Multiply-substituted fullerenes and methods for their preparation and characterization

Publications (1)

Publication Number Publication Date
AU5864796A true AU5864796A (en) 1996-11-29

Family

ID=27034088

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58647/96A Abandoned AU5864796A (en) 1995-05-19 1996-05-17 Multiply-substituted fullerenes and methods for their prepar ation and characterization

Country Status (2)

Country Link
AU (1) AU5864796A (en)
WO (1) WO1996036631A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028103A (en) * 1994-09-16 2000-02-22 Children's Medical Center Corporation Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
US6265443B1 (en) 1996-06-03 2001-07-24 Washington University Method for treating neuronal injury with carboxyfullerene
DE69701458T2 (en) * 1996-06-03 2000-09-07 Hoffmann La Roche USE OF BUCKMINSTERFULLEREN FOR TREATING NEUROTOXIC INJURIES
US6992079B2 (en) 1997-11-20 2006-01-31 President Fellows of Harvard College Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
US6800658B2 (en) 1997-11-20 2004-10-05 Children's Medical Center Corporation Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
BR9815617A (en) 1997-11-20 2001-10-16 Harvard College Substituted 11-phenyl-dibenzazepine compounds, pharmaceutical composition based on said compounds, and methods for inhibiting the proliferation of mammalian cells and for treating or preventing a disorder caused by abnormal cell proliferation
EP1420066A3 (en) * 1998-03-10 2005-01-05 Fujisawa Pharmaceutical Co., Ltd. Use of fullerene derivatives as DNA compaction agent
US7671230B2 (en) 2001-10-01 2010-03-02 Tda Research, Inc. Derivatization and solubilization of insoluble classes of fullerenes
US7812190B2 (en) 2001-10-01 2010-10-12 Tda Research, Inc. Derivatization and solubilization of fullerenes for use in therapeutic and diagnostic applications
US7794682B1 (en) 2005-02-28 2010-09-14 Tda Research, Inc. Methods for fullerene recovery
PL421804A1 (en) * 2017-06-06 2018-12-17 Uniwersytet Warszawski Modified nanostructural carbon matrix, a system that contains such matrix and a biosensor comprising such a system and method for determination of analyte in a sample, using the biosensor system as well as application of benzopyrrolic acid for modification of the nanostructural carbon matrix

Also Published As

Publication number Publication date
WO1996036631A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
AU6257196A (en) Electrosurgical apparatus for laparoscopic and like procedur es
AU5536096A (en) Large area submucosal graft constructs and method for making the same
AU5367696A (en) Ellipsometric microscope
AU2591697A (en) Oil-sorbing article and methods for making and using same
AU3628795A (en) Accelerator-base methods and apparatus for measurement-while-drilling
AU4767396A (en) Process for preparing 2-oxindoles and n-hydroxy-2-oxindoles
EP0808841A3 (en) Supported metallocene complex and process for its preparation
AU2324195A (en) Electrosurgical apparatus
AU3087895A (en) Towing apparatus
AU1425997A (en) Method and apparatus for making insignias
AU7252096A (en) Lumpectomy facilitating apparatus and methods related thereto
AU4161797A (en) Benzoperimidine-carboxylic acids and derivatives thereof
AU1046197A (en) An impedance means
AU6531596A (en) Lan tester
AU5433696A (en) Resurfaced carpet and process for making the same
AU5622196A (en) Pyridazinone derivatives and processes for preparing the same
AU691390B2 (en) Process for producing N-arylhydroxylamines and N-hetarylhydroxylamines
AU5864796A (en) Multiply-substituted fullerenes and methods for their prepar ation and characterization
AU696316B2 (en) Process for producing pentafluoroethane and tetrafluorochloroethane
AU678745B2 (en) Blower apparatus
AU4062195A (en) Monolayer curl-salting process and apparatus
AUPO304296A0 (en) Continuous decatising process and apparatus
AU686535B1 (en) Branched cyclodextrins and method for producing them
AU1366099A (en) Distribution chassis
AU5659296A (en) Pearl protein (nacrein) and process for producing the same